| Literature DB >> 36241756 |
Said Rammali1, Lahoucine Hilali2, Khadija Dari2, Bouchaib Bencharki2, Abdellatif Rahim3, Mohammed Timinouni4, Fatima Gaboune5, Mohamed El Aalaoui6, Abdelkrim Khattabi2.
Abstract
The increasing demand for new bioactive compounds to combat the evolution of multi-drug resistance (MDR) requires research on microorganisms in different environments in order to identify new potent molecules. In this study, initial screening regarding the antimicrobial activity of 44 Actinomycetes isolates isolated from three soil samples from three different extremely cold sites in Morocco was carried out. Primary and secondary screening were performed against Candida albicans ATCC 60,193, Escherichia coli ATCC 25,922, Staphylococcus aureus ATCC 25,923, Bacillus cereus ATCC 14,579, other clinical MDR bacteria, and thirteen phytopathogenic fungi. Based on the results obtained, 11 active isolates were selected for further study. The 11microbial isolates were identified based on morphological and biochemical characters and their molecular identification was performed using 16S rRNA sequence homology. The UV-visible analysis of dichloromethane extracts of the five Streptomyces sp. Strains that showed high antimicrobial and antioxidant (ABTS 35.8% and DPPH 25.6%) activities revealed the absence of polyene molecules. GC-MS analysis of the dichloromethane extract of E23-4 as the most active strain revealed the presence of 21 volatile compounds including Pyrrolopyrazine (98%) and Benzeneacetic acid (90%). In conclusion, we studied the isolation of new Streptomyces strains to produce new compounds with antimicrobial and antioxidant activities in a cold and microbiologically unexplored region of Morocco. Furthermore, this study has demonstrated a significant (P < 0.0001) positive correlation between total phenolic and flavonoid contents and antioxidant capacity, paving the way for the further characterization of these Streptomyces sp. isolates for their optimal use for anticancer, antioxidant, and antimicrobial purposes.Entities:
Mesh:
Substances:
Year: 2022 PMID: 36241756 PMCID: PMC9568536 DOI: 10.1038/s41598-022-21644-z
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.996
Physico-chemical analysis of soil samples.
| Physico-chemical parameters | Site A | Site B | Site C |
|---|---|---|---|
| Textural soil types | Sandy-silty | Sandy | Sandy-silty |
| Clay (%) | 19.97 | 5.00 | 9.99 |
| Sandy (%) | 50.08 | 90.01 | 55.04 |
| Silt (%) | 29.95 | 4.99 | 34.97 |
| pH | 8.30 | 8.57 | 7.29 |
| EC (ds/m) | 0.20 | 0.30 | 0.15 |
| OM (%) | 3.48 | 5.65 | 7.61 |
| TN (%) | 0.15 | 0.24 | 0.33 |
| Mg (%) | 1.09 | 0.31 | 1.59 |
| Al (%) | 5.91 | 1.08 | 6.70 |
| K (%) | 1,59 | 2.79 | 1.39 |
| Ca (%) | 2,83 | 23.00 | 0.74 |
| S (%) | 0.11 | 0.03 | 0.01 |
| Cl (%) | 0.15 | 0.04 | – |
| P (%) | 0.31 | 0.00 | 0.36 |
| Fe (%) | 14.80 | 1.63 | 12.58 |
| Mn (%) | 0.13 | 0.04 | 0.20 |
| Cu (%) | 0.03 | – | 0.01 |
| Zn (%) | 0.01 | 0.01 | 0.03 |
Site A (Sebt Jahjouh El Hajeb); Site B (Forest of Ain Vittel Ifrane); Site C (Forest of Azrou);
(–) not detectable, EC electrical conductivity, OM organic matter, TN total nitrogen.
Total number of Streptomyces isolates obtained from the three studied sites (A, B and C) according to the culture media used.
| Collection site of soil samples | Number of | Total number of | Number of colonies with distinct morphological characteristics in each medium | Total number of isolates | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| M2 | Ben | GLM | GA | M2 | Ben | GLM | GA | |||
| Site A | 80 | 9 | 16 | 12 | 117 | 4 | 2 | 4 | 1 | 11 |
| Site B | 60 | 26 | 14 | 4 | 104 | 7 | 4 | 2 | 1 | 14 |
| Site C | 45 | 12 | 14 | 14 | 85 | 9 | 4 | 3 | 2 | 18 |
| Total | 185 | 47 | 44 | 30 | 306 | 20 | 11 | 9 | 4 | 43 |
Site A (SebtJ ahjouh El Hajeb); Site B (Forest of Ain Vittel Ifrane); and Site C (Forest ofAzrou).
Figure 1Primary screening (antibacterial activity) using the double layer method on ISP2 medium.
Figure 2Antibacerial activity of pure Actinomycetes isolates by the double layer method on ISP2 medium.
Figure 3Primary screening (antifungal activity) by the double layer method on ISP2 medium against Candida albicans ATCC 60,193.
Figure 4Primary screening (antifungal activity) by the double layer method on ISP2 medium against phytopathogenic fungi.
Figure 5Antifungal activity of Actinomycetes pure isolates by the double layer method on ISP2 medium.
Secondary screening (antibacterial activity) by disc diffusion method.
| Test strains | Dichloromethane extracts of bioactive isolates (inhibition zones in mm) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| E23-2 | E23-3 | E23-4 | E23-8 | E23-9 | E23-10 | E23-11 | E24-9 | E25-9 | E25-11 | E25-12 | PC | |
| Clinical | 22.5 ± 0.71 | 18 ± 2.12 | 22 ± 2.83 | 15.5 ± 0.71 | 21.5 ± 2.12 | 11.5 ± 0.71 | 15 ± 1.41 | 10.5 ± 0.72 | 19.5 ± 0.70 | 7 ± 0.0 | 23.5 ± 2.1 | 27 ± 1.41 |
| 25.5 ± 0.71 | – | 28 ± 1.41 | 22 ± 1.41 | 19 ± 1.41 | 22.5 ± 0.71 | 26.5 ± 2.12 | 17.5 ± 3.54 | 36.5 ± 2.12 | 14.5 ± 0.71 | 35.5 ± 2.12 | 35.5 ± 0.71 | |
| Clinical | – | – | – | 8 ± 0 | 8 ± 1.41 | – | – | – | 7.5 ± 0.71 | – | 7.5 ± 0.71 | 25.5 ± 2.12 |
| 25.5 ± 0.71 | – | 25 ± 1.41 | 10 ± 0.0 | 13.5 ± 2.12 | 19 ± 1.41 | 20.5 ± 0.71 | 12.5 ± 0.71 | 21.5 ± 0.71 | 18 ± 1.41 | – | 25.5 ± 0.71 | |
| Clinical | 22.5 ± 0.71 | 17.5 ± 0.7 | 19 ± 1.41 | 14.5 ± 0.71 | 8.5 ± 0.71 | 11 ± 2.83 | 18 ± 1.41 | 10.5 ± 0.72 | 16.5 ± 0.71 | – | 23 ± 2.83 | 24 ± 1.41 |
| 25 ± 1.41 | 18.5 ± 2.12 | 20.5 ± 0.71 | 14.5 ± 0.71 | 8.5 ± 0.71 | 10 ± 1.41 | 19 ± 1.41 | 7 ± 0.00 | 19.5 ± 0.71 | – | 25 ± 1.41 | 11 ± 1.41 | |
| 24.5 ± 3.53 | – | 21.5 ± 0.71 | 13.5 ± 0.71 | 10.5 ± 0.71 | 16.5 ± 2.12 | 19.5 ± 0.71 | 13 ± 1.41 | 22.5 ± 0.71 | 17.5 ± 0.71 | 17.5 ± 0.71 | 27.5 ± 2.12 | |
| 24 ± 1.41 | – | 23 ± 0.0 | 14.5 ± 0.71 | 10.5 ± 0.71 | 14.5 ± 0.71 | 21.5 ± 0.10 | 14 ± 0.0 | 22 ± 2.82 | 19.5 ± 4.95 | 19 ± 1.41 | 28 ± 4.24 | |
(–) no inhibition zone, PC positive control (Streptomycine) and disc diameter = 6 mm.
Figure 6Secondary screening (antibacterial activity) by the disc diffusion method on MH medium.
Secondary screening (antifungal activity) by disc diffusion method.
| Test strains | Dichloromethane extracts of active isolates (inhibition zone in mm) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| E23-2 | E23-3 | E23-4 | E23-8 | E23-10 | E23-11 | E25-9 | E25-11 | E25-12 | PC | |
| 22.5 ± 0.71 | – | 21.5 ± 0.71 | 125 ± 0,71 | 17.5 ± 2.12 | 19.5 ± 0.71 | 22 ± 1.41 | 16.5 ± 2.12 | 20.5 ± 0.71 | 27 ± 2.83 | |
| 18.5 ± 2.12 | 22 ± 2.82 | – | 13.5 ± 2.12 | – | 22 ± 1.41 | – | 19 ± 1.41 | – | 31.5 ± 0.71 | |
| – | – | – | – | – | 20.5 ± 0.71 | – | 14.5 ± 0.71 | – | 19.5 ± 0.71 | |
| 11 ± 1.41 | – | – | – | – | – | – | – | – | 28.5 ± 2.12 | |
| – | – | 16 ± 2.82 | – | – | – | – | – | – | 27 ± 1.41 | |
| – | 10.5 ± 0.71 | – | – | – | 14.5 ± 0.71 | – | 9.5 ± 0.71 | – | 27.5 ± 0.71 | |
| – | 9.5 ± 0.71 | – | – | – | 19.5 ± 2.12 | – | – | – | 26.5 ± 0.71 | |
| – | – | – | – | – | 21 ± 1.41 | – | 16.5 ± 2.12 | – | 16.5 ± 2.12 | |
(–) no inhibition zone, PC positive control (Cycloheximide) and disc diameter = 6 mm.
Figure 7Secondary screening (antifungal activity) by the disc diffusion method on MH medium.
Figure 8Kinetics of pH evolution and production of antibiotics against Bacillus cereus ATCC 14,579.
Cultural, micro-morphological, biochemical and physiological characteristics of Actinomycetes isolates.
| Characteristics | E23-2 | E23-3 | E23-4 | E23-8 | E23-9 | E23-10 | E23-11 | E24-9 | E25-9 | E25-11 | E25-12 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Ribose | − | + | + | − | − | − | − | 2 + | + | − | + |
| Melezitose | + | 3 + | − | − | − | − | + | − | − | − | − |
| Manitol | 3 + | 3 + | 3 + | 3 + | − | 2 + | 3 + | − | 3 + | 3 + | 3 + |
| Trehalose | 3 + | 3 + | 3 + | 3 + | 3 + | 3 + | 3 + | 3 + | 3 + | 3 + | 3 + |
| Cellobiose | 3 + | 3 + | 3 + | 3 + | 3 + | 3 + | 3 + | 3 + | 3 + | 3 + | 3 + |
| Sucrose | 3 + | 3 + | 3 + | 3 + | 3 + | 2 + | 3 + | 3 + | 3 + | − | 3 + |
| Raffinose | 3 + | 3 + | 3 + | 3 + | 3 + | 2 + | 3 + | − | 3 + | 3 + | 3 + |
| Xylose | 3 + | 3 + | + | 3 + | + | 3 + | 2 + | 3 + | 3 + | 3 + | 3 + |
| Melibiose | 3 + | 3 + | 3 + | 3 + | − | + | 3 + | − | 3 + | 3 + | 3 + |
| Mannose | 3 + | 3 + | 3 + | 3 + | 3 + | 2 + | 3 + | 3 + | 3 + | 3 + | 3 + |
| Fructose | 3 + | 2 + | 3 + | 3 + | 3 + | 2 + | 3 + | + | 3 + | 3 + | 3 + |
| Galactose | 3 + | 3 + | 3 + | + | 3 + | 3 + | 3 + | + | 3 + | 3 + | 3 + |
| Maltose | 3 + | 2 + | 2 + | 2 + | 2 + | + | 3 + | 3 + | 2 + | 3 + | 3 + |
| Glucose | 3 + | 3 + | 3 + | 3 + | 3 + | 3 + | 3 + | 3 + | 3 + | 3 + | 3 + |
| ISP1 | 3 + | 3 + | 2 + | 3 + | 3 + | 2 + | 2 + | 3 + | 2 + | 3 + | 3 + |
| ISP2 | 3 + | 3 + | 3 + | 3 + | 3 + | 3 + | 2 + | 3 + | 3 + | 3 + | 3 + |
| ISP4 | 3 + | 3 + | 3 + | 3 + | 3 + | 3 + | 2 + | 3 + | 2 + | 3 + | 3 + |
| ISP5 | 3 + | 3 + | 3 + | 3 + | 3 + | 3 + | 2 + | 3 + | 3 + | 3 + | 3 + |
| ISP7 | 3 + | 3 + | 3 + | 3 + | 3 + | 3 + | + | 3 + | 2 + | 3 + | 3 + |
| GYEA | 3 + | 3 + | 3 + | 3 + | 3 + | 3 + | 3 + | 3 + | 2 + | 3 + | 3 + |
| 4,63 | − | − | − | − | − | − | − | − | − | − | − |
| 5,33 | 2 + | + | + | + | + | 2 + | + | + | + | 2 + | + |
| 6,41 | 2 + | 3 + | 3 + | 3 + | 2 + | 2 + | 2 + | + | 2 + | 3 + | 2 + |
| 7,31 | 3 + | 3 + | 2 + | 3 + | 3 + | 3 + | 2 + | 2 + | 3 + | 3 + | 3 + |
| 8,28 | 3 + | 3 + | 3 + | 3 + | 3 + | 3 + | 3 + | 3 + | 3 + | 3 + | 3 + |
| 9,27 | 3 + | 2 + | 2 + | 3 + | 3 + | 3 + | 3 + | 3 + | 3 + | 2 + | 3 + |
| 10,03 | 2 + | 2 + | + | 3 + | + | 2 + | 3 + | 3 + | + | 2 + | 3 + |
| 1% | 3 + | 3 + | 3 + | 3 + | 3 + | 3 + | 3 + | 3 + | 3 + | 3 + | 3 + |
| 2% | 3 + | 3 + | 3 + | 3 + | 2 + | 3 + | 3 + | 3 + | 3 + | 3 + | 3 + |
| 3% | 3 + | 3 + | 2 + | 3 + | + | 3 + | 3 + | 2 + | 3 + | 3 + | 3 + |
| 4% | 3 + | 3 + | 2 + | 2 + | + | 3 + | 2 + | + | 3 + | 3 + | 2 + |
| 5% | 2 + | 3 + | + | + | + | 2 + | 2 + | + | 2 + | 3 + | 2 + |
| 7% | 2 + | + | − | + | − | 3 + | + | − | − | − | + |
| 10% | − | − | − | − | − | − | − | − | − | − | − |
| 4 °C | − | − | − | − | − | − | − | − | − | − | − |
| 28 °C | 3 + | 3 + | 3 + | 3 + | 3 + | 3 + | 3 + | 3 + | 3 + | 3 + | 3 + |
| 37 °C | 3 + | 3 + | + | 2 + | 2 + | 2 + | 2 + | 3 + | + | 3 + | 2 + |
| 46 °C | − | − | − | − | − | − | − | − | − | − | − |
(−) no growth; (+) low growth; (2+) intermediate growth; (3) good growth.
Figure 9Dendrogram showing the evolutionary relationship of the Actinomycetes isolates.
Figure 10Phylogenetic tree based on 16S rRNA gene sequences of Actinomycetes isolates.The phylogenetic tree based on the 16S rRNA gene was established by statistical method (Neighbour-Joining Tree test), showing the evolutionary relationships among the 11 Actinomycetes isolates marked in red circle and their closest known taxa. Each branch in the tree is associated with a bootstrap value (a percentage ranging from 0 to 100%) which indicates the number of times it has been found during the repetitions and thus determines its credibility, only the values (> 40%) are displayed. The bar (0.010), represents the number of substitutions per nucleotide position (1% of divergence between sequences). GenBank accession numbers are shown in parentheses.
Total phenolic and flavonoid contents of dicholoromethane extract of Actinomycetes.
| Dichloromethane extracts | Total phenol’s contents (mg GAE/mg extract) | Total flavanoids contents (mg QE/mg extract) |
|---|---|---|
| E23-2 | 0.36 ± 0.012C | 0.028 ± 0.005C |
| E23-4 | 0.42 ± 0.004B | 0.044 ± 0.001A |
| E23-11 | 0.64 ± 0.008A | 0.031 ± 0.002B |
| E25-11 | 0.49 ± 0.016B | 0.035 ± 0.002B |
| E25-12 | 0.10 ± 0.001D | 0.032 ± 0.005B |
Values expressed are means ± SD (n = 3).
In each column, averaged means within followed by the same letters are not significantly different according to one-way (ANOVA) using Tukey's multiple comparisons test, P < 0.05.
Antioxidant activity of isolates dichloromethane extracts in different antioxidant assays (ABTSand DPPH).
| Antioxidant activity | ||
|---|---|---|
| ABTS radical Scavenging activity (%) | DPPH radical Scavenging activity (%) | |
| E23-2 | 33.81 ± 3.12B**** | 21.17 ± 3.18B** |
| E23-4 | 35.79 ± 0.22B**** | 25.55 ± 0.27B *** |
| E23-11 | 29.45 ± 2.06C**** | 21.88 ± 4.19B*** |
| E25-11 | 32.67 ± 0.36B**** | 24.45 ± 2.37B** |
| E25-12 | 29.31 ± 0.71C**** | 19.95 ± 1.09B*** |
| Trolox | 66.67 ± 0.74A | ND |
| Ascorbic Acid | ND | 76.38 ± 1.82A |
Values expressed are means ± SD (n = 3).
In each column, averaged means within followed by the same letters are not significantly different according to one-way (ANOVA) using Tukey's multiple comparisons test, P < 0.05.
ND not determined.
**P < 0.01, ***P < 0.001, ****P < 0.0001 indicates statistically significant difference.
Figure 11Pearson correlation graphics. (A) Pearson correlation between ABTS and total phenolic content, (B) Pearson correlation between ABTS and flavonoids content, (C) Pearson correlation between DPPH and total phenolic content, and (D) Pearson correlation between DPPH and flavonoids content. “****” (P < 0.0001) highly significant between tests.
Figure 12UV–visible spectra for the five active crude dichloromethane extracts. (A) Brut extract of Streptomyces sp. E23-2 OM883988, (B) brut extract of Streptomyces sp. E23-4 OM883990, (C) brut extract of Streptomyces sp. E23-11 OM883994, (D) brut extract of Streptomyces sp. E25-11 OM883997, (E) brut extract of Streptomyces bellus E25-12 OM883998.
21 volatile compounds identified by GC–MS from dichloromethane crude extract of Streptomyces sp. E23-4 OM883990 strain. RT: Retention time; M.W.: Molecular Weight.
| RT (time) | Area (%) | M.W. (g/mol) | Molecular formula | Coompound name | Reported bioactivity |
|---|---|---|---|---|---|
| 9.197 | 3.37 | 94.20 | C2H6S2 | Disulfide, dimethyl | Antioxidant, Antifungal, Analgesic effect[ |
| 9.366 | 0.28 | 85.13 | C3H3NS | 1,3-thiazole | Antibacterial activity[ |
| 9.467 | 1.25 | 94.10 | C6H5OH | Phenol | Antimicrobial activity, antibacterial activity, and antioxidant activity[ |
| 9.580 | 0.30 | 112.08 | C4H4N2O2 | Maleic hydrazide | Anti-tumorigenic effect[ |
| 10.267 | 0.18 | 126.11 | C6H6O3 | Methyl 2-furoate | Antifungal[ |
| 10.583 | 0.67 | 126.11 | C6H6O3 | Maltol | Antioxidant, Anti-inflammatory, and Antitumor[ |
| 10.955 | 0.76 | 144.12 | C6H8O4 | 4H-Pyran-4-one, 2,3-dihydro-3,5-dihydroxy-6-methyl- | Antioxidant[ |
| 12.746 | 0.80 | 136.14 | C8H8O2 | Benzeneacetic acid | Antifungal, Antimicrobial, and Antioxidant[ |
| 19.767 | 0.40 | 222.24 | C12H14O4 | Diethyl Phthalate | Antimicrobial, Antifungal[ |
| 24.962 | 1.57 | 283.36 | C15H25NO4 | l-Proline, N-allyloxycarbonyl-, isohexyl ester | Not yet reported |
| 26.866 | 3.22 | 409.6 | C25H47NO3 | l-Leucine, N-cyclopropylcarbonyl-, pentadecyl ester | Antibacterial[ |
| 27.328 | 6.21 | 154.3 | C4H10S3 | Diethyl trisulphide | Antimicrobial[ |
| 27.553 | 1.83 | 451.68 | C27H49NO4 | l-Proline, N-allyloxycarbonyl-, octadecyl ester | Not yet reported |
| 34.968 | 2.77 | 244.29 | C14H16N2O2 | Pyrrolo [1, 2-a] pyrazine-1, 4-dione, hexahydro-3-(phenylmethyl) | Antifungal, Antioxidant, and Anibacterial[ |
| 47.307 | 3.54 | 323.41 | C18H17N3OS | Acetamide, N-[4-[2-[(3-methylphenyl) amino]-4-thiazolyl]phenyl]- | Anticancer activity[ |
| 47.454 | 4.76 | 323.39 | C20H21NO3 | Indole-3-carboxylic acid, 5-methoxy-2-methyl-1-(3-methylphenyl)-, ethyl ester | Anticonvulsant, Antioxidant, Anticancer, Antibacterial and Anti-inflammatory Antitubercular, Antimalarial Resistance mediator against necrotrophic pathogens [ |
| 47.961 | 0.22 | 222.40 | C13H22OSi | Thymol, TMS derivative | Anibacterial, Antifungal, Antioxidant, Anticancer[ |
| 48.524 | 0.36 | 264.46 | C13H20N2SSi | 1, 2-Benzisothiazol-3-amine, TBDMS derivative | Antifungal, Antioxidant and Anti-proliferative[ |
| 48.829 | 0.36 | 222.40 | C13H22OSi | Thymol, TMS derivative | Anibacterial, Antifungal, Antioxidant, Anticancer[ |
| 48.975 | 0.21 | 222.47 | C12H22Si2 | 1,2-Bis (trimethylsilyl) benzene | Antimicrobial, Antioxidant, Anibacterial[ |
| 49.381 | 0.44 | 207.27 | C15H13N | Benzo[h]quinoline, 2,4-dimethyl- | anti-inflammatory[ |